Natalie C. Holles's Net Worth

$25.9 Million

Estimate Recalculated Nov 11, 2024 08:52AM EST

Who is Natalie C. Holles?

Natalie C. Holles has an estimated net worth of $25.9 Million. This is based on reported shares across multiple companies, which include HYPERION THERAPEUTICS INC, Allakos Inc., Day One Biopharmaceuticals, Inc., Rubius Therapeutics, Inc., Audentes Therapeutics, Inc., and Third Harmonic Bio, Inc..

SEC CIK

Natalie C. Holles's CIK is 0001580111

Past Insider Trading and Trends

2019 was Natalie C. Holles's most active year for acquiring shares with 9 total transactions. Natalie C. Holles's most active month to acquire stocks was the month of April. 2019 was Natalie C. Holles's most active year for disposing of shares, totalling 11 transactions. Natalie C. Holles's most active month to dispose stocks was the month of December. 2019 saw Natalie C. Holles paying a total of $1,891,934.34 for 293,977 shares, this is the most they've acquired in one year. In 2020 Natalie C. Holles cashed out on 424,787 shares for a total of $6,266,340.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HYPERION THERAPEUTICS INC No price found

SVP, Business Development

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-18.45K
$46.00
-$848,792.00
0
May 7
Form 4
+314.47%
14K
—
—
18.45K
Feb 9
Form 4
-10.96%
-548.00
$24.28
-$13,305.44
4.45K
Jan 2
Form 4
∞
5K
—
—
5K
Mar 11
Form 4
—
0
—
—
0
Aug 16
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found

Allakos Inc. (ALLK) Snapshot price: $0.648

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Jan 4
Form 3
—
0
—
—
0
No matching records found

Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 21
Form 3
—
0
—
—
0
No matching records found

Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Mar 29
Form 3
—
0
—
—
0
No matching records found

Audentes Therapeutics, Inc. No price found

President and COO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-104.44K
$60.00
-$6,266,340.00
0
Jan 15
Form 4
+90.92%
49.73K
$36.03
-$3,926,060.66
104.44K
Dec 12
Form 4
-0.91%
-505.00
$59.21
-$29,901.05
54.7K
Dec 5
Form 4
-0.91%
-505.00
$31.02
-$15,665.10
55.21K
Sep 5
Form 4
-1.78%
-1.01K
$37.31
-$37,645.79
55.71K
Jun 5
Form 4
+69.88%
23.33K
—
—
56.72K
Feb 6
Form 4
+33.08%
8.3K
$2.76
$22,948.67
33.39K
Jan 24
Form 4
+25.45%
5.09K
$2.76
$14,073.34
25.09K
Jun 1
Form 4
—
0
—
—
0
May 7
Form 4
—
0
—
—
0
Nov 16
Form 4
∞
20K
$2.76
$55,200.00
20K
May 31
Form 4
—
0
—
—
0
Jan 25
Form 3
—
0
—
—
0
No matching records found